Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (642)	2/15/1999 6:01:00 AM
From: puborectalis	Read Replies (1) \| Respond to of 2001

Be careful of investing in biotech firms with little or no high scientific visibility. The market floor is strewn with stocks that were driven up on hope and nothing else. For example....Humascan...Cell pathways....Cephalon....Viragen...etc. High profile journals include Spine, NEJM., American J of Gastroenterology not second rate journals as have been mentioned on this thread. It is,alright to be an investor in biotech companies but since 1992 they have underperformed this market in a big way unless you include majors like PFE,WLA,and LILLY.

To: scaram(o)uche who wrote (642)	2/19/1999 3:08:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2001

In the conference call, I believe that it was mentioned, in passing, that 2331 partnering could include dementia. Increasingly, I feel that GLIA will be able to partner the H3-receptor antagonist program for a given indication, and retain a lucrative piece(s) as their very own. Analysts don't yet realize what a bit of luck would do for this business plan, and the size of the markets that 2331 wants to play in. Ritalin sells. We just got $0.10/share for the quarter based on modest, if rapid, penetration of the -L market. -P is in pivotal trials addressing a market that is approximately 3X that of -L. GT 2331 has now completed single-dose phase I testing and targets markets that are even larger..... and growing rapidly (including adult ADD). Our concepts are changing too..... is nicotine bad for you, even if it's addicting? In the day of "new medicine" colliding with life in the 21st century, GLIA is well-positioned.